We are a well-established European manufacturer highly specialized in the production of complete lines for the aseptic processing of injectable products, supplying pharmaceutical companies worldwide.
Founded in 1989 in the Lake Como area (Italy) where its headquarter and manufacturing sites are still based, Steriline is now operating in more than 50 countries around the world. Steriline can rely on a network of around 180 people including both direct employees and external partners, and 40 sales representatives to ensure an effective presence in the global marketplace. Export is today representing over 90% of the companys total turnover with more than 1400 Steriline machines already installed mainly in Asia, Europe and in the USA.
Focusing on specialization, advanced engineering and collaborative partnership, Steriline aims at becoming a preferred aseptic processing manufacturer for the pharmaceutical industry. As per its mission, Steriline is committed to provide customers with distinct, tailored and durably reliable solutions to help them meet a growing demand for improved efficiency, consistent quality and enhanced safety across the sector.
First established as a manufacturer of Washing Machines and Depyrogenation Tunnels only, in 2007 Steriline launched its first complete line including Isolators as well as Filling Machines and Capping Machines. Since then, Steriline has been able to significantly evolve into a single-source supplier of equipment solutions for the primary packaging of injectable drugs, ranging from complete lines to stand-alone machines. Furthermore, as a testament to its strong commitment to R&D and technological innovation, in 2014 Steriline took on a pioneering role by introducing, as first in the aseptic processing market, a robotic application with no need of format parts and featuring a “zero-loss philosophy”. Nowadays, Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanic and robotic applications for the aseptic processing of toxic or non-toxic products, liquid or powders, in vials, ampoules, cartridges or syringes.
More specifically, Steriline complete lines cover all operations and types of equipment spanning from Washing Machines, Depyrogenation Tunnels, Filling and Capping Machines to External Decontamination Machines and barrier systems such as LAF, oRABS, cRABS and pharmaceutical Isolators.
With a look to the near future of the pharmaceutical industry, where robots are increasingly defining new paradigms in manufacturing, Steriline is currently strongly widening its portfolio of robotic solutions to further help injectable drug manufacturers face the new global challenges effectively.
As another crucial asset in its business strategy, Steriline relationship with customers is shaped around a dialogue that is frequent, open and ongoing at all stages of product lifecycle. Whether a company is looking for a standard single machine or a customized robotic line, Steriline can build on an inventive approach to engineering and advanced project management capabilities to deliver the most effective solutions in response to each company specific needs.
Besides offering complete planning and project management, Steriline supports the customer along the entire process going from the design and manufacturing phases through to installation, validation, qualification and maintenance. Additionally, Steriline provides extensive Customer Support services through high-standard technical assistance secured by a department staffed by skilled engineers.
Established as a family-owned business more than 25 years ago, Steriline is guided today by its founder, Gerardo Fumagalli, as Chief Executive Officer together with Ilaria Fumagalli, Chief Operating Officer, and Federico Fumagalli, Chief Commercial Officer.